Le Lézard

Privo Technologies Begins Dosing PRV131 in Arm 3 Of Clinical Study CLN-004, A First-In-Class Cisplatin Intratumoral Injectable Targeting Oral Cavity Cancer

Privo Technologies, Inc., today announced that the first patient has been dosed in its first-in-human clinical trial ...
Le Lézard

ALAMO GROUP INC. TO ACQUIRE PETERSEN INDUSTRIES, EXPANDING ITS INDUSTRIAL EQUIPMENT PRODUCT OFFERING

Alamo Group Inc. , a leading global manufacturer of high-quality industrial and vegetation management equipment, today announced that it has signed a definitive agreement to acquire Petersen ...
pharmaphorum

Solid Bio hit as FDA slaps clinical hold on DMD gene therapy

The FDA has placed another clinical hold on a gene therapy for Duchenne muscular dystrophy developed by Solid Biosciences, pulverising its share price. The halt of the IGNITE DMD trial was prompted by ...
Yahoo Finance

Solid Power, Inc. (SLDP)

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.